Celia Sequera

5PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

Celia Sequera, Margherita Grattarola, Floriane Cannet

|Mar 10, 2022
Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Patricia Rada, Fabienne Lamballe, Elena Carceller-López

|Apr 07, 2021
C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.

Sara Manzano, Alvaro Gutierrez-Uzquiza, Paloma Bragado

Pageof 1